Uncategorised - European Medical Journal

MRI Radiomics Predicts HER-2 Status in Breast Cancer with High Accuracy

Understand how multiparametric MRI radiomics predicts HER-2 status in breast cancer with high accuracy.

RSV Poses Greater Heart Risk Than COVID or Flu

Adults hospitalized with respiratory syncytial virus (RSV) face a significantly greater risk of acute cardiovascular events compared to those admitted for COVID-19 or influenza, according to new findings from a population-based study.

Smart Dental Floss Tracks Cortisol for Easy Stress Management

Novel dental floss device measures stress hormone cortisol for easy, real-time monitoring at home.

NHS Launches Groundbreaking Blood Test for Patients with Cancer

Following a successful pilot involving around 10,000 patients with non-small cell lung cancer, NHS England is now rolling out the test nationally.

ERA 2025: Pegcetacoplan Shows Strong Kidney Benefit in Rare Diseases

Pegcetacoplan demonstrated a significant reduction in proteinuria and signs of kidney damage in patients with C3G or IC-MPGN and nephrotic-range proteinuria, according to VALIANT Phase 3 results.

CAR-T Cell Therapy in MS

CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025

5 Jun 2025

COPD Device Selection Tool

Interactive Devise Selection tool to help select the optimal inhalation therapy device based on patient’s cognitive function, manual dexterity, and peak inspiratory flow for COPD

Infectious Disease Diagnostics: The New Era of STD Screening

In the final episode of our miniseries, Jonathan sits down with global diagnostics leader Rosanna Peeling to explore the life-saving role of diagnostics in global health, sexually transmitted diseases, and COVID-19.

EASL Congress 2025 Interview: Debbie Shawcross

It always takes a village to organise an event the size of the EASL Congress. We had close to 8,000 registrants, so it was a huge…

Rafael Fonseca

Hema Now: Episode 18: Myeloma Genetics, CAR-T, and Emerging Immunotherapies

Rafael Fonseca, Consultant, Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona, USA